CL
Colgate-Palmolive Co.
NYSE · Consumer Defensive · Household & Personal Products · US
$94.11
+1.55%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- $0.93
- Revenue estimate
- $5.3B
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- $0.99
- EPS estimate
- $0.95
- Revenue actual
- $5.4B
- Revenue estimate
- $5.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +3.5%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $97
- PT range
- $87 – $109
- Analysts
- 8
5 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | $0.95 | $0.99 | Beat 4.54% | $5.4B |
| May 1, 2026 | $0.94 | $0.97 | Beat 2.86% | $5.3B |
| Jan 30, 2026 | $0.91 | $0.95 | Beat 4.17% | $5.2B |
| Oct 31, 2025 | $0.89 | $0.91 | Beat 2.25% | $5.1B |
| Aug 1, 2025 | $0.90 | $0.92 | Beat 2.34% | $5.1B |
| Apr 25, 2025 | $0.86 | $0.91 | Beat 6.06% | $4.9B |
| Jan 31, 2025 | $0.90 | $0.91 | Beat 0.89% | $4.9B |
| Oct 25, 2024 | $0.89 | $0.91 | Beat 2.02% | $5.0B |
| Jul 26, 2024 | $0.87 | $0.91 | Beat 4.60% | $5.1B |
| Apr 26, 2024 | $0.81 | $0.86 | Beat 6.17% | $5.1B |
| Jan 26, 2024 | $0.85 | $0.87 | Beat 2.47% | $5.0B |
| Oct 27, 2023 | $0.80 | $0.86 | Beat 7.63% | $4.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026